🇺🇸 FDA
Pipeline program

Babaodan oral capsule

EHBHKY2017-01-016

Approved small_molecule active

Quick answer

Babaodan oral capsule for Hepatocellular Carcinoma is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Hepatocellular Carcinoma
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials